EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unlocking the Potential of Ganoderma lucidum (Curtis): Botanical Overview, Therapeutic Applications, and Nanotechnological Advances

Ana Eira iD, Maria Beatriz S Gonçalves, Yannick Stéphane Fotsing Fongang iD, Cátia Domingues iD, Ivana Jarak, Filipa Mascarenhas-Melo iD, Ana Figueiras iD

Pharmaceutics · 26.03.2025 · 17 (4) · 422

DOI: 10.3390/pharmaceutics17040422 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 26.03.2025. Verfasst von Ana Eira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ganoderma lucidum (GL), commonly known as the “Lingzhi” or “Reishi” mushroom, has long been recognized for its potential health benefits and medicinal properties in traditional Chinese medicine. The unique potential combination of bioactive compounds present in GL, such as triterpenoids, polysaccharides, and peptides, has inspired interest in leveraging their therapeutic potential In recent years, the emerging field of nanotechnology has opened up new possibilities for using the remarkable properties of GL at the nanoscale. Objetive: The main objective of this review is to explore the unique potential of GL in traditional and innovative therapies, particularly in cancer treatment, and to assess how nanotechnology-based strategies can enhance its therapeutic applications.is to explore.

Results

Nanotechnology-based strategies have been investigated for the efficient extraction and purification of bioactive compounds from GL. Additionally, nanocarriers and nanoformulations have been developed to protect these sensitive bioactive compounds from degradation, ensuring their stability during storage and transportation. The use of GL-based nanomaterials has shown promising results in several biomedical applications, namely due to their anticancer activity by targeting cancer cells, inducing apoptosis, and inhibiting tumor growth.

Conclusions

The combination of GL and nanotechnology presents an exciting frontier in the development of novel therapeutic and biomedical applications. Nevertheless, further research and development in this interdisciplinary field are warranted to fully exploit the synergistic benefits offered by GL and nanotechnology. Future prospects include the development of robust clinical trials focused on GL nanotechnology-based cancer therapies to clarify mechanisms of actions and optimize formulations, ultimately leading to innovative solutions for human health and well-being.

Schlagwörter

Stichwörter der Autor:innen

Ganoderma lucidumbioactive compoundscancer therapydrug deliverynanoparticlesnanotechnologypolysaccharidestriterpenoids

Autor:innen und Institutionen

  • Laboratory of Drug Development and Technologies, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
  • Higher Teachers' Training College, The University of Maroua, Maroua P.O. Box 55, Cameroon.
  • Associated Laboratory for Green Chemistry (LAQV) of the Network of Chemistry and Technology (REQUIMTE), Group of Pharmaceutical Technology, University of Coimbra, 3000-548 Coimbra, Portugal.
  • Institute for Clinical and Biomedical Research (iCBR) Area of Environment Genetics and Oncobiology (CI MAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
  • Higher School of Health, Polytechnic Institute of Guarda, 6300-307 Guarda, Portugal.
  • BRIDGES-Biotechnology Research, Innovation and Design of Health Products, Polytechnic University of Guarda, 6300-559 Guarda, Portugal.

ORCID-Profile: Ana Eira, Yannick Stéphane Fotsing Fongang, Cátia Domingues, Filipa Mascarenhas-Melo, Ana Figueiras

Förderung

  • Fundação para a Ciência e Tecnologia
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Eira, A., Gonçalves, M. B. S., Fongang, Y. S. F., Domingues, C., Jarak, I., Mascarenhas-Melo, F., & Figueiras, A. (2025). Unlocking the Potential of Ganoderma lucidum (Curtis): Botanical Overview, Therapeutic Applications, and Nanotechnological Advances. Pharmaceutics, 17(4), 422. https://doi.org/10.3390/pharmaceutics17040422

Vancouver

Eira A, Gonçalves MBS, Fongang YSF, Domingues C, Jarak I, Mascarenhas-Melo F, et al. Unlocking the Potential of Ganoderma lucidum (Curtis): Botanical Overview, Therapeutic Applications, and Nanotechnological Advances. Pharmaceutics. 2025;17(4):422. doi:10.3390/pharmaceutics17040422

BibTeX
@article{Eira2025,
  author = {Eira, Ana and Gonçalves, Maria Beatriz S and Fongang, Yannick Stéphane Fotsing and Domingues, Cátia and Jarak, Ivana and Mascarenhas-Melo, Filipa and Figueiras, Ana},
  title = {Unlocking the Potential of Ganoderma lucidum (Curtis): Botanical Overview, Therapeutic Applications, and Nanotechnological Advances},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {422},
  doi = {10.3390/pharmaceutics17040422}
}
Kostenlos starten →